We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Fresenius Helios Unit to Acquire Rhoen Hospitals

By HospiMedica International staff writers
Posted on 24 Sep 2013
In a move designed to create Europe’s biggest chain of private hospitals, Fresenius (Bad Homburg, Germany) has agreed to pay Rhoen-Klinikum (RHK; Bad Neustadt, Germany) the sum of EUR 3.07 billion.

The acquisition will make Fresenius Helios, the company’s healthcare arm, the largest private hospital operator in Europe, with 117 hospitals across Germany and nearly EUR 5.5 billion in sales. More...
The purchase adds a further 43 hospitals with a total of approximately 11,800 beds, as well as 15 outpatient facilities. Under the terms of the agreement, The University Hospital Giessen and Marburg, the hospitals in Bad Neustadt (including the RHK headquarters), Bad Berka, and Frankfurt/Oder will remain with RHK. These hospitals will enter into a cooperation agreement with Fresenius, becoming part of a network offering innovative care models across Germany.

The agreement follows a failed 2012 bid to gain at least 90% of RHK share, which was foiled by minority shareholder Asklepios Kliniken (Hamburg, Germany). The new deal, however, is for a smaller portion of the company, and will leave RHK with 5,300 hospital beds, generating about EUR 1 billion in annual revenue. The sale proceeds will enable RHK to repay debt and about EUR 200 million will be left over for investments. RHK is also proposing a special dividend to shareholders of as much as EUR 1.9 billion.

“This compelling transaction provides a unique opportunity to create a nationwide hospital network and to establish Europe’s largest private hospital operator,” said Ulf Mark Schneider, CEO of Fresenius. “The clinics we are acquiring from Rhön-Klinikum are a perfect strategic and geographic fit with Helios’ existing portfolio, and will allow us to develop innovative approaches to health care. We are looking forward to working with the employees of the newly acquired clinics to advance our joint commitment to high-quality patient care.”

“With the support of the supervisory board, we have made a ground-breaking and at the same time extraordinarily sustainable decision. Through its critical mass, the ‘new Rhön’ is well positioned to deliver significant additional medical and economic growth,” said Martin Siebert, MD, PhD, CEO of RHK. “We are starting from a stable earnings position and believe that this can be considerably increased. The ‘new Rhön’ with its unique structure and offering will be even more attractive in the future.”

Related Links:

Fresenius
Rhoen-Klinikum
Asklepios Kliniken



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Isolation Stretcher
IS 736
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.